Reference 2018-214

REF:          2018-214 

Subject:      Research into Non-Small Cell Lung Cancer (NSCLC) 

 

 

Request:

Please provide the following information relating to NSCLC[1] patients treated[2] by your Trust in the 3 months, December 2017 to February 2018 inclusive.

If data is not held in a sufficient way within your Trust systems, i.e. if for example you are unable to distinguish between cancer type and/or stage, please indicate accordingly within the tables below.

  Total number treated Stage IIIB/IV NSCLC Patients If unable to provide number of stage IIIB/IV NSCLC patients treated, please indicate the level at which data has been provided:
Patients with NSCLC Stage IIIB/IV (Stage 3b/4)[3]   Total number NSCLC  patients  
Other (please specify)  
Data not held/accessible  

 

Of the Stage IIIB/IV NSCLC patients, please indicate the number of patients treated by your Trust in the 3 months December 2017 to February 2018 inclusive, with the following therapies.

  Total number treated Stage IIIB/IV NSCLC Patients If unable to provide number of stage IIIB/IV NSCLC patients treated, please indicate the level at which data has been provided:

 

Docetaxel (mono or combination therapy )   Total number NSCLC  patients  
Other (please specify)  
Data not held/accessible  
Atezolizumab (Tecentriq)   Total number NSCLC  patients  
Other (please specify)  
Data not held/accessible  
Nivolumab (Opdivo)   Total number NSCLC  patients  
Other (please specify)  
Data not held/accessible  
Pembrolizumab (Keytruda)   Total number NSCLC  patients  
Other (please specify)  
Data not held/accessible  

 

If your trust does not treat these cancers and you refer your patients to another trust, please state to which trust(s) patients are referred:

 

 

 

Response:

Please find information attached.

2018-214 – FOI request – Research into Non-Small Cell Lung Cancer (NSCLC) [207 kb] PDF

 

[1] ICD10 C33, C34

[2] Please indicate the number of patients (excluding clinical trial patients) treated with any active anti-cancer drug treatment.

[3] TNM staging for Stage IIIB NSCLC = Any T, N3, M0 or T4, N2, M0;    TNM staging for Stage IV NSCLC = Any T, any N, M1

Please include number for both those patients that present at stage III/IV and also those whose cancer has progressed to stage III/IV